July 20 (SeeNews) - UK-based investment firm BC Partners said it has agreed to sell a majority stake in Greece-founded drug delivery technology company Pharmathen SA to Swiss private equity investor Partners Group in a deal that values the target company at about 1.6 billion euro ($1.88 billion).